Biggest stock movers today: ADBE, GERN, and more [Seeking Alpha]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Seeking Alpha
Her are some of Friday's biggest stock movers: Biggest stock gainers Shares of Geron ( NASDAQ: GERN skyrocketed 94% after FDA advisors voted 12 to 2 in favor of its blood cancer therapy, imetelstat, for transfusion-dependent anemia in myelodysplastic syndrome (MDS) patients. The FDA's cancer drug experts viewed imetelstat as a late-line option and believed its benefits outweighed the risks. Imetelstat is Geron's lead asset, under FDA review for lower-risk MDS, with a decision expected by June 16. While the FDA usually follows advisory committee recommendations, they are non-binding. Madrigal Pharmaceuticals' ( NASDAQ: MDGL ) shares surged 28% after the Food and Drug Administration (FDA) approved its lead asset, resmetirom, as the first U.S.-approved therapy for nonalcoholic steatohepatitis (NASH). This new pill, called REZDIFFRA, is a big deal in medical history because, until now, there were no FDA-approved treatments for NASH, which is a serious liver condition. NASH, n
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron Co. (NASDAQ: GERN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.MarketBeat
- Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Reports First Quarter 2024 Financial Results and Business HighlightsBusiness Wire
- Baird downgrades Geron to neutral, cites valuation concerns [Seeking Alpha]Seeking Alpha
GERN
Earnings
- 5/2/24 - Beat
GERN
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 3/27/24 - Form ARS
- GERN's page on the SEC website